Skip to Main Content

DexCom, Inc.

DXCM Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

$DXCM is featured in our Tina Smith strategy.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of DXCM by members of U.S. Congress

Politician Type Traded
Michael T. McCaul House / R Sale $15,001 - $50,000 Oct 27, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 29, 2025
Michael T. McCaul House / R Purchase $1,001 - $15,000 Sep 22, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Aug 21, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Aug 21, 2025
Michael T. McCaul House / R Purchase $1,001 - $15,000 Aug 07, 2025
Michael T. McCaul House / R Purchase $1,001 - $15,000 Aug 07, 2025
Michael T. McCaul House / R Purchase $15,001 - $50,000 Aug 04, 2025
Michael T. McCaul House / R Purchase $15,001 - $50,000 Aug 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Aug 04, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Aug 04, 2025
Michael T. McCaul House / R Purchase $1,001 - $15,000 Jul 30, 2025
Michael T. McCaul House / R Purchase $1,001 - $15,000 Jul 30, 2025
Michael T. McCaul House / R Purchase $1,001 - $15,000 Jul 05, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Jun 27, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Jun 16, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 May 28, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 May 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 12, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 23, 2025
Michael T. McCaul House / R Purchase $50,001 - $100,000 Apr 08, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Apr 08, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 Apr 07, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Feb 25, 2025
Kevin Hern House / R Sale $50,001 - $100,000 Dec 31, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 14, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Oct 11, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 09, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 05, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 31, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Oct 10, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 02, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep 12, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Sep 06, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Aug 29, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Aug 21, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 May 23, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 29, 2022
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep 28, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 23, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 01, 2022
Ro Khanna House / D Sale $15,001 - $50,000 Jul 19, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Jun 17, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 23, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 10, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 05, 2022
DXCM Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
DXCM Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
DXCM Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in DXCM holdings by institutional investors

Quarterly net insider trading by DXCM's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $370,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $290,000 Jul 21, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $270,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $260,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $130,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $170,000 Sep 06, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $160,000 Sep 06, 2024 Issue: Trade (domestic/foreign) Medicare/Medicaid Health Issues
  • $56,500 Jan 03, 2024 Issue: Medicare/Medicaid Health Issues
  • $56,500 Oct 19, 2023 Issue: None
  • $67,450 Jul 12, 2023 Issue: Medicare/Medicaid
  • $62,000 Jan 10, 2023 Issue: Health Issues
  • $56,500 Oct 12, 2022 Issue: Economics/Economic Development Medicare/Medicaid
  • $57,000 Jul 12, 2022 Issue: Health Issues
  • $57,000 May 05, 2022 Issue: Medicare/Medicaid Health Issues
  • $57,000 Mar 23, 2022 Issue: Medicare/Medicaid Health Issues
  • $57,000 Oct 05, 2021 Issue: None
  • $57,000 Jul 02, 2021 Issue: None
  • $58,600 Apr 14, 2021 Issue: None
  • $56,274 Jan 08, 2021 Issue: HEALTH ISSUES
  • $57,250 Oct 19, 2020 Issue: MEDICARE/MEDICAID
  • $58,600 Jul 13, 2020 Issue: MEDICARE/MEDICAID
  • $58,632 Apr 13, 2020 Issue: None
  • $57,250 Jan 10, 2020 Issue: None
  • $56,274 Oct 08, 2019 Issue: Health Issues Medicare/Medicaid
  • $52,675 Jul 12, 2019 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 22, 2019 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 22, 2019 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 19, 2018 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues
  • $180,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues
  • $250,000 Apr 19, 2018 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 19, 2018 Issue: Medicare/Medicaid Health Issues
  • $7,651 Jan 16, 2018 Issue: Health Issues Medicare/Medicaid
  • $9,700 Oct 23, 2017 Issue: Medicare/Medicaid
  • $6,750 Jul 21, 2017 Issue: Health Issues
  • $8,375 Jul 21, 2017 Issue: Health Issues
  • $80,000 Jul 18, 2017 Issue: Medicare/Medicaid Health Issues
  • $130,000 Apr 20, 2017 Issue: Health Issues Medicare/Medicaid
  • $25,650 Jan 23, 2017 Issue: Health Issues
  • $120,000 Jan 23, 2017 Issue: Medicare/Medicaid Health Issues
  • $12,750 Oct 20, 2016 Issue: Health Issues
  • $150,000 Oct 17, 2016 Issue: Medicare/Medicaid Health Issues
  • $130,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues
  • $36,000 Jul 20, 2016 Issue: Health Issues
  • $36,000 Apr 20, 2016 Issue: Health Issues
  • $20,000 Apr 19, 2016 Issue: Health Issues
  • $70,000 Jan 15, 2016 Issue: Health Issues
  • $70,000 Oct 14, 2015 Issue: Health Issues
  • $60,000 Jul 16, 2015 Issue: Health Issues
  • $50,000 Apr 18, 2015 Issue: Health Issues
  • $20,000 Jan 18, 2015 Issue: Health Issues
  • $40,000 Oct 16, 2014 Issue: Health Issues
  • $60,000 Jul 17, 2014 Issue: Health Issues
  • $20,000 Apr 20, 2014 Issue: Health Issues
  • $40,000 Aug 12, 2007 Issue: Health Issues
  • $100,000 Feb 09, 2007 Issue: Health Issues

DXCM Estimated quarterly lobbying spending

DXCM Revenue by Segment or Geography

By Segment
By Geography
DXCM Income Statement
DXCM Balance Sheet
DXCM Cash Flow
U.S. Patents

New DXCM patent grants

  • Patent Title: Display screen or portion thereof with graphical user interface Jun. 03, 2025
  • Patent Title: Medical device inserter Jan. 14, 2025
  • Patent Title: Combination medical device receiver and display Dec. 03, 2024
  • Patent Title: Transcutaneous analyte sensor applicator Nov. 26, 2024
  • Patent Title: Display screen or portion thereof with a graphical user interface Oct. 08, 2024
  • Patent Title: Medical device electronic module Aug. 13, 2024
  • Patent Title: Base for medical device electronic module Aug. 13, 2024
  • Patent Title: Display screen or portion thereof with graphical user interface for analyte data presentation Feb. 21, 2023
  • Patent Title: Display screen or portion thereof with graphical user interface for analyte data presentation Feb. 21, 2023
  • Patent Title: Combination medical device receiver and display Jan. 04, 2022
  • Patent Title: Transcutaneous analyte sensor applicator Jul. 27, 2021
  • Patent Title: Wearable medical monitoring device Jul. 27, 2021
  • Patent Title: Medical device inserter Mar. 30, 2021
  • Patent Title: Display screen or portion thereof with graphical user interface Mar. 30, 2021
  • Patent Title: Display screen or portion thereof with icon for presentation of analyte data Nov. 10, 2020
  • Patent Title: Transcutaneous analyte sensor applicator Jun. 23, 2020
  • Patent Title: Wearable medical monitoring device Dec. 17, 2019
  • Patent Title: Display screen or portion thereof with a graphical user interface with icons Dec. 17, 2019
  • Patent Title: Medical device electronic module Jun. 11, 2019
  • Patent Title: Display screen or portion thereof with icon for presentation of analyte data Apr. 30, 2019
  • Patent Title: Display screen or portion thereof with graphical user interface Apr. 23, 2019
  • Patent Title: Display screen or portion thereof with graphical user interface for analyte data presentation Apr. 02, 2019
  • Patent Title: Display screen or portion thereof with graphical user interface for analyte data presentation Apr. 02, 2019
  • Patent Title: Display screen or portion thereof with icon Mar. 19, 2019
  • Patent Title: Display screen or portion thereof with a graphical user interface with icons Dec. 04, 2018
  • Patent Title: Base for medical device electronic module Oct. 23, 2018
  • Patent Title: Display screen or portion thereof with icon for presentation of analyte data Jun. 12, 2018
  • Patent Title: Display screen or portion thereof with icon Jun. 12, 2018
  • Patent Title: Display screen or portion thereof with graphical user interface for analyte data presentation Jun. 12, 2018
  • Patent Title: Display screen or portion thereof with graphical user interface for analyte data presentation Jun. 05, 2018
  • Patent Title: Medical device inserter May. 01, 2018
  • Patent Title: Display screen or portion therof with graphical user interface Mar. 20, 2018
  • Patent Title: Display screen or portion thereof with icon for presentation of analyte data Oct. 10, 2017
  • Patent Title: Medical device receiver and display in combination Aug. 15, 2017
  • Patent Title: Base for medical device electronic module Aug. 15, 2017
  • Patent Title: Medical device inserter Aug. 15, 2017
  • Patent Title: Medical device electronic module Aug. 08, 2017
  • Patent Title: Display screen or portion thereof with a graphical user interface with icons Jun. 20, 2017
  • Patent Title: Display screen or portion thereof with graphical user interface and icons Jun. 13, 2017
  • Patent Title: Display screen or portion thereof with graphical user interface Mar. 07, 2017
  • Patent Title: Display screen or portion thereof with icon Feb. 21, 2017
  • Patent Title: Display screen or portion thereof with graphical user interface for analyte data presentation Feb. 21, 2017
  • Patent Title: Display screen or portion thereof with graphical user interface for presentation of analyte data Feb. 21, 2017
  • Patent Title: Display screen or portion thereof with graphical user interface Feb. 14, 2017
  • Patent Title: Display screen or portion thereof with icon for presentation of analyte data Dec. 06, 2016
  • Patent Title: Display screen or portion thereof with a graphical user interface with icons Sep. 27, 2016
  • Patent Title: Charging cradle for medical device May. 13, 2014
  • Patent Title: Dual electrode system for a continuous analyte sensor Jan. 07, 2014
  • Patent Title: Electrode systems for electrochemical sensors May. 22, 2012
  • Patent Title: Dual electrode system for a continuous analyte sensor Dec. 20, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to DXCM from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
DXCM News

Recent insights relating to DXCM

CNBC Recommendations

Recent picks made for DXCM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DXCM

DXCM Analyst Ratings

DXCM Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
DXCM Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $DXCM stock a Buy, Sell, or Hold?

  • What is the price target for $DXCM stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

DXCM Top Shareholders
Shareholder
Shares Held
DXCM Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $DXCM stock?

  • Who owns the most shares of $DXCM stock?

  • What funds own $DXCM stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

DXCM Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view DXCM Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About DXCM

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

  • Address San Diego, CA
  • Market Cap 23.5 billion
  • Employees 10,300
  • Industrial Classification Surgical & Medical Instruments & Apparatus
Back To Top